With a market capitalization (market cap) of $2.02B — a measure of how much the company is worth — Inspire Medical Systems, Inc. ranks #2,032 among the 2,510 companies tracked, and 248th in Healthcare as of October 3, 2026. Shares trade at $69.97, down 1.14% on the day.
of 2,510 tracked
Market-cap change uses historical capitalization records. Share-price returns are a different series — they can diverge when the share count changes. Those returns are not a CAGR until you pick a start value, an ending value, and years. CAGR calculator. Market cap vs. stock price.
Year-end values and the chart both come from historical market-cap records, not from applying today's share count to past prices. Latest historical observation October 2, 2026. Ranking headline cap is the snapshot figure as of October 3, 2026.
| Year | As of | Market cap | Annual change | Year-end close |
|---|---|---|---|---|
| 2026 | Oct 2, 2026 | $2.02B | -23.78% | $69.97 |
| 2025 | Dec 31, 2025 | $2.65B | -51.93% | $92.23 |
| 2024 | Dec 31, 2024 | $5.51B | -8.30% | $185.38 |
| 2023 | Dec 29, 2023 | $6B | -17.60% | $203.43 |
Ranking figure $2.02B as of October 3, 2026.
Inspire Medical Systems, Inc.'s ranking market cap is the provider-reported capitalization on the same snapshot as the rest of this site, with a share price of $69.97 as of October 2, 2026. Charts and the year-end table use a separate historical market-cap series, last observed at $2.02B on October 2, 2026. See how the ranking works.
Live shares outstanding are not on the quote used for price, so this page does not invent a current share count. Shares outstanding vs. float.
The latest annual report (FY 2025) used a weighted-average 29,368,892 shares. That figure is an average for the year, not the live count in the market-cap formula.
Book equity: assets minus liabilities on the latest annual report.
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Not in this snapshot
FY 2025 net worth
Largest U.S.-listed names in the same FMP sector — not a hand-picked competitor set.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #14 | Eli Lilly and Company LLY | $1.08T | -0.61% |
| #21 | Johnson & Johnson JNJ | $617.01B | -1.02% |
| #24 |
Inspire Medical Systems, Inc. operates as a medical technology enterprise, concentrating on the development and commercialization of advanced, minimally intrusive therapies for patients diagnosed with obstructive sleep apnea (OSA) across both domestic U.S. and international markets. A cornerstone of its product portfolio is the Inspire system, an innovative neurostimulation solution that offers a safe and proven effective treatment for individuals experiencing moderate to severe forms of OSA.
Summary from the company profile (Financial Modeling Prep). Principal financial figures above are for FY 2025.
Visit websiteAs of October 3, 2026, Inspire Medical Systems, Inc. (INSP) is worth $2.02B — that is its market capitalization, the total value of its outstanding shares on MarketCapLens.
A company’s net worth is its shareholders’ equity: assets minus liabilities on the balance sheet. That is book equity, not market cap. For FY 2025, Inspire Medical Systems, Inc.’s book equity is about $781.16M. Market cap is the market value of the outstanding shares. As of October 3, 2026, its market cap is $2.02B. Book equity is an accounting remainder; market cap is a trading value. Neither is a person’s net worth.
Inspire Medical Systems, Inc. ranks #2,032 among the 2,510 companies tracked on MarketCapLens. In Healthcare it ranks #248 of 350.
Fundamentals are annual. Figures labeled with their fiscal year. Live ratios use the current price against those annual earnings.
| 2022 |
|---|
| Dec 30, 2022 |
| $7.29B |
| +15.11% |
| $251.88 |
| 2021 | Dec 31, 2021 | $6.33B | — | $230.06 |
|---|
Last observation of each calendar year from historical market-cap records. The current year is through the latest date, not a completed year-end. Share-price close is the matching session for context — we do not rebuild cap from today's share count.
Not in this snapshot
FY 2025
| $464.35B |
| +1.11% |
| #36 | Merck & Co., Inc. MRK | $356.4B | +0.34% |
| #38 | UnitedHealth Group Incorporated UNH | $337.74B | +1.83% |
| #52 | Novartis AG NVS | $268B | -0.04% |
Companies immediately above and below in the overall ranking. They may be in a different sector.
| Rank | Company | Market cap | 1D |
|---|---|---|---|
| #2029 | The Bancorp, Inc. TBBK | $2.03B | -0.27% |
| #2030 | Arxis, Inc. Class A Common Stock ARXS | $2.03B | +5.28% |
| #2031 | Interface, Inc. TILE | $2.03B | +1.28% |
| #2033 | UroGen Pharma Ltd. URGN | $2.02B | +2.10% |
| #2034 | City Holding Company CHCO | $2.02B | +1.01% |
| #2035 | LCI Industries LCII | $2.01B | +0.85% |
Inspire Medical Systems, Inc.’s ranking market cap of $2.02B comes from the same snapshot as the rest of this site, as of October 3, 2026. It is not share price multiplied by the FY 2025 weighted-average share count of 29,368,892. The historical market-cap series last observed $2.02B on October 2, 2026.
Over the past year, Inspire Medical Systems, Inc.’s market cap is down 5.91%, using historical market-cap records rather than today’s share count applied to past prices.
Inspire Medical Systems, Inc. (INSP) shares trade at $69.97, down 1.14% on the day, as of October 3, 2026.
Inspire Medical Systems, Inc. trades at a live price-to-earnings (P/E) ratio of 14.1, using the latest share price divided by the latest annual earnings per share. That is not the same as a fiscal-year reported P/E.